Mason Street Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-80,309
| Closed | -$18.5M | – | 74 |
|
|
2020
Q4 | $18.5M | Sell |
80,309
-1,953
| -2% | -$450K | 0.31% | 54 |
|
|
2020
Q3 | $20.9M | Sell |
82,262
-1,719
| -2% | -$426K | 0.41% | 38 |
|
|
2020
Q2 | $19.8M | Sell |
83,981
-795
| -0.9% | -$181K | 0.4% | 42 |
|
|
2020
Q1 | $17.2M | Hold |
84,776
| – | – | 0.39% | 45 |
|
|
2019
Q4 | $20.4M | Sell |
84,776
-662
| -0.8% | -$146K | 0.39% | 43 |
|
|
2019
Q3 | $16.5M | Sell |
85,438
-1,549
| -2% | -$297K | 0.34% | 53 |
|
|
2019
Q2 | $16M | Sell |
86,987
-1,789
| -2% | -$320K | 0.33% | 51 |
|
|
2019
Q1 | $16.9M | Sell |
88,776
-1,063
| -1% | -$203K | 0.34% | 55 |
|
|
2018
Q4 | $17.5M | Sell |
89,839
-1,154
| -1% | -$225K | 0.42% | 40 |
|
|
2018
Q3 | $18.9M | Sell |
90,993
-2,449
| -3% | -$483K | 0.39% | 42 |
|
|
2018
Q2 | $17.2M | Buy |
93,442
+327
| +0.4% | +$57.8K | 0.38% | 44 |
|
|
2018
Q1 | $15.9M | Sell |
93,115
-7,998
| -8% | -$1.47M | 0.36% | 47 |
|
|
2017
Q4 | $17.6M | Sell |
101,113
-179
| -0.2% | -$31.7K | 0.39% | 48 |
|
|
2017
Q3 | $18.9M | Sell |
101,292
-841
| -0.8% | -$149K | 0.45% | 38 |
|
|
2017
Q2 | $17.6M | Buy |
102,133
+361
| +0.4% | +$58.7K | 0.44% | 37 |
|
|
2017
Q1 | $16.7M | Buy |
101,772
+7
| +0% | +$1.16K | 0.43% | 38 |
|
|
2016
Q4 | $14.9M | Buy |
101,765
+527
| +0.5% | +$79.3K | 0.4% | 37 |
|
|
2016
Q3 | $16.9M | Buy |
101,238
+54
| +0.1% | +$9.13K | 0.48% | 33 |
|
|
2016
Q2 | $15.4M | Buy |
101,184
+1,004
| +1% | +$156K | 0.45% | 40 |
|
|
2016
Q1 | $15M | Buy |
100,180
+1,635
| +2% | +$243K | 0.46% | 38 |
|
|
2015
Q4 | $16M | Buy |
98,545
+438
| +0.4% | +$68.8K | 0.5% | 34 |
|
|
2015
Q3 | $13.6M | Buy |
98,107
+204
| +0.2% | +$32.2K | 0.46% | 38 |
|
|
2015
Q2 | $15M | Buy |
97,903
+174
| +0.2% | +$27.9K | 0.46% | 38 |
|
|
2015
Q1 | $15.6M | Sell |
97,729
-35,361
| -27% | -$5.57M | 0.47% | 35 |
|
|
2014
Q4 | $21.2M | Sell |
133,090
-3,454
| -3% | -$538K | 0.15% | 175 |
|
|
2014
Q3 | $19.2M | Sell |
136,544
-630
| -0.5% | -$82.3K | 0.15% | 165 |
|
|
2014
Q2 | $16.2M | Sell |
137,174
-84,730
| -38% | -$9.81M | 0.13% | 201 |
|
|
2014
Q1 | $27.4M | Sell |
221,904
-2,590
| -1% | -$314K | 0.22% | 104 |
|
|
2013
Q4 | $25.6M | Sell |
224,494
-11,865
| -5% | -$1.35M | 0.21% | 109 |
|
|
2013
Q3 | $26.5M | Buy |
236,359
+77,836
| +49% | +$8.44M | 0.3% | 69 |
|
|
2013
Q2 | $15.6M | Buy |
+158,523
| New | +$16.5M | 0.17% | 159 |
|
Other funds holding AMGN
Mason Street Advisors's AMGN Position: Q1 2021 in Review
Mason Street Advisors sold out of Amgen (AMGN) in Q1 2021, closing a stake of 80,309 shares — an estimated $18.5M sold.
Mason Street Advisors first reported a position in AMGN in Q2 2013 and held it in 31 quarters. The position peaked at $27.4M in Q1 2014. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.
- Mason Street Advisors reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 80,309 Amgen shares in Q1 2021, an estimated $18.5M.
- Mason Street Advisors first reported a position in Amgen in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's Amgen position peaked at $27.4M in Q1 2014.
- 2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.